Store

Home | Store | Histology and Cytology IVD Market Update, 2022

Histology and Cytology IVD Market Update, 2022

Publication Date: May 20, 2022

SKU: 22-035

Tags: Diagnostic Instruments, Histology and Cytology, In Vitro Diagnostics (IVD)

Pages: 40

SKU: 22-035

Kalorama Information’s Histology and Cytology IVD Market Update report provides a comprehensive competitive analysis of the histology/cytology market from 2021 to 2026. Histology and cytology are crucial components of pathological labs, delivering vital information about cells, tissues, and organs, which are essential for diagnosing various diseases. Physicians depend heavily on these analyses for making informed decisions regarding cancer and other diseases, thereby shaping treatment plans and prognoses.

 

Key Insights:

  • Market Analysis: Detailed examination of market trends, with forecasts extending to 2026.
  • Technological Advancements: Insights into how advancements in digital imaging, quantitative microscopy, precision microscopy, artificial intelligence, and virtual histology are revolutionizing the industry.
  • Segment Analysis: The market is segmented into five key areas:
    • Traditional Non-PAP Stains
    • PAP
    • In Situ Hybridization
    • Immunohistochemistry
    • HPV

 

Featuring:

  • Market Data: All market data pertains to the world market at the manufacturers’ level. The base year for data is 2021, with data projections provided for 2026, including compound annual growth rates (CAGRs) for the period.
  • Regional Analysis: Market breakdowns for the United States, Europe, Asia-Pacific, and the Rest of the World.
  • Analysis of market growth driven by demographic trends, new developments, innovative technology, and global expansion.

 

Competitive Landscape:

  • Profiles and competitive analysis of five key market participants:
    • Agilent
    • Danaher
    • Hologic
    • Illumina
    • Roche

 

Table: Global Histology/Cytology Sales, by Type, 2021-2026 (in millions $)

 Type IVD Sales 2021 % Mkt IVD Sales 2026 % Mkt CAGR %
Pap tests $XX Million XX% $XX Million XX% XX%
in situ hybridization $XX Million XX% $XX Million XX% XX%
immunohistochemistry $XX Million XX% $XX Million XX% XX%
traditional non-Pap stains $XX Million XX% $XX Million XX% XX%
HPV – DNA $XX Million XX% $XX Million XX% XX%
 TOTAL $XX Million XX% $XX Million XX% XX%

Source: Kalorama Information

For further details and to purchase directly, please contact us.

Table of Contents

Chapter 1: Executive Summary

Industry at a Glance

Scope and Methodology

Size and Growth of the Market

  • Figure 1-1: Global Histology IVD Market, 2021-2026 ($millions)

Competitive Outlook

 

Chapter 2: Market Analysis

Overview Of Histology/Cytology

Histology Market Segments

  • Table 2-1:  Global Histology/Cytology Sales by Type, 2021-2026 ($ millions) (Pap Tests, in situ hybridization, immunohistochemistry, traditional non-Pap stains, HPV, TOTAL)
  • Figure 2-1: Histology/Cytology Diagnostic Market Distribution by Broad Test Category, 2021

Market Segment by Test Type

Traditional Tissue Stains

  • Table 2-2: Selected Vendors of Traditional Histology Stains

PAP Tests

  • Table 2-3: Primary and Secondary Prevention of Cervical Cancer, Screening Responses by Country, 2019 (last updated 2020-02-12)

Immunohistochemistry and In-Situ Hybridization

  • Table 2-4: Selected in Situ Hybridization-based Tests
  • Table 2-5: Selected IHC Test Innovations

HPV

  • Figure 2-2: HPV Screening Market: HPV DNA and Pap Test Distribution of Sales, 2021
  • Table 2-6: Global HPV Molecular (DNA/RNA) Test Sales Distribution by Region, 2021 (North America, Europe, Asia Pacific, RoW)
  • Table 2-7: Selected HPV Test Innovations

Market by Region

  • Table 2-8: Global Histology/Cytology Sales Distribution by Region, 2021 (%) (North America, Europe, Asia Pacific, RoW)

Competitive Analysis

  • Table 2-9: Revenues of the Major Histology Companies, 2017-2021 ($ millions, estimated)
  • Table 2-10: 2022 Pathology Launches by Roche

The Commercial Outlook for Histology

 

Chapter 3: Major Market Participants

Roche Diagnostic

  • Table 3-1: Roche Diagnostic Corporate Summary
  • Figure 3-1: Roche Diagnostics Revenue by Product Group, Full Year Results 2020, 2021, CHF MN

Danaher Corporation

  • Table 3-2: Danaher Corporation Summary
  • Figure 3-2: Danaher Diagnostic Segment Performance, Full Year Results, 2020,2021

Agilent

  • Table 3-3: Agilent Corporate Summary
  • Table 3-4: Agilent Revenues 2017-2021 (millions $)

Illumina, Inc

  • Table 3-5:  Illumina Corporate Summary
  • Table 3-6: Illumina Diagnostics Revenues 2017-2021 (millions $)

Hologic

  • Table 3-7: Hologic Corporate Summary
  • Figure 3-3: Hologic Diagnostic Segment Performance, Full Year Results, FY 2020, FY 2021, $M

Our Knowledge Center provides access to

all market reports